Intec Pharma Ltd. Stock News

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Hold rating on Intec Pharma ( NTEC – Research Report ). The company’s shares closed last Thursday at $0.21, close to its

IMMURON LTD/S (NASDAQ:IMRN) and Intec Pharma (NASDAQ:NTEC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends,

As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ.Canadian medical marijuana producer Aphria Inc (NYSE: APH

Gainers Can-Fite BioPharma Ltd. (NYSE: CANF) rose 56.3% to $2.00 in pre-market trading after declining over 12% on Thursday. Intec Pharma Ltd. (NASDAQ: NTEC) rose 40% to $0.28...

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the fourth quarter and year ended December 31, 2019 and provides a corporate update.

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences in March.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Bioscie

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (

Gainers • Cleveland BioLabs, Inc. (NASDAQ:CBLI) stock rose 18.4% to $3.73 during Friday's pre-market session. • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shares...

In addition, the Company granted the underwriter a 30-day option to purchase up to an additional 2,437,500 ordinary shares and/or warrants to purchase up to 2,437,500 ordinary shares at the public off

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announced that it intends to offer and sell a combination of ordinary shares (or pre-funded warrants to purchase ordinary shares in li

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today provides a business and clinical update on its development programs with the Company's proprietary oral drug delivery system, the Acco

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towar

Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces the termination of the Feasibility and Option agreement with Novartis for the development of a custom-designed Accordion Pil